Express Scripts Subpoenaed as the Feds Initiate Investigations into its Relationships with Drug Manufacturers and Others

October 31, 2016 — The U.S. Department of Justice (DOJ) and two U.S. Attorney's offices have officially entered the national discussion on drug pricing and the role of Pharmacy Benefit Managers (PBMs) with the initiation of investigatory proceedings against Express Scripts. In a recent Securities and Exchange Commission filing, Express Scripts disclosed that it has received [...]